Reduced incidence of hemophagocytic lymphohistiocytosis in Japan during the COVID-19 pandemic.

Sakamoto, Kenichi; Ono, Rintaro; Doi, Takehiko; Koga, Yuhki; Shioda, Yoko

Sakamoto, Kenichi; Ono, Rintaro; Doi, Takehiko; Koga, Yuhki; Shioda, Yoko.

Sakamoto K; Department of Pediatrics, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan. sken1@belle.shiga-med.ac.jp.
Ono R; Department of Pediatrics, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan. sken1@belle.shiga-med.ac.jp.
Doi T; Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan.
Koga Y; Department of Pediatrics, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
Shioda Y; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Int J Hematol ; 115(3): 446-448, 2022 03.

Article in English | MEDLINE | ID: covidwho-1701551

Subject(s)

COVID-19; Lymphohistiocytosis, Hemophagocytic; Humans; Incidence; Japan/epidemiology; Lymphohistiocytosis, Hemophagocytic/epidemiology; Lymphohistiocytosis, Hemophagocytic/etiology; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphohistiocytosis, Hemophagocytic / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Asia Language: English Journal: Int J Hematol Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: S12185-022-03302-2

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google